Broniscer, Alberto <br/><br/>
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jan 2009 
 - 701-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-08-1923  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anticonvulsants--pharmacology<br/>Brain Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Erlotinib Hydrochloride<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Protein Kinase Inhibitors--administration & dosage<br/>Quinazolines--administration & dosage<br/>Young Adult